LeMaitre Vascular, Inc. (LMAT) is a publicly traded Healthcare sector company. As of July 15, 2026, LMAT trades at $97.94 with a market cap of $2.29B and a P/E ratio of 35.79. LMAT moved -2.50% today. Year to date, LMAT is +20.67%; over the trailing twelve months it is +16.38%. Its 52-week range spans $71.42 to $118.01. Analyst consensus is buy with an average price target of $123.00. Rallies surfaces LMAT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for LMAT, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $97.94 |
| Market Cap | $2.29B |
| P/E Ratio | 35.79 |
| EPS | $2.76 |
| Dividend Yield | 0.25% |
| 52-Week High | $118.01 |
| 52-Week Low | $71.42 |
| Volume | 192.04K |
| Avg Volume | 0 |
| Revenue (TTM) | $256.28M |
| Net Income | $62.40M |
| Gross Margin | 72.39% |
7 analysts cover LMAT: 0 strong buy, 5 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $123.00.